Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi a/s - amisulprid - tabletter - 200 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - amisulprid - tabletter - 200 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - amisulprid - tabletter - 200 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi a/s - amisulprid - tabletter - 50 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - amisulprid - tabletter - 50 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

nordic prime aps - amisulprid - tabletter - 50 mg

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptika, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

Denmaki - Kidenmaki - SEGES Landbrug & Fødevarer

trifolio-m gmbh - azadirachtin - emulsionskoncentrat - 10 g/l azadirachtin

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

astellas pharma europe b.v. - gilteritinib fumarate - leukæmi, myeloid, akut - antineoplastiske midler - xospata er angivet som monoterapi til behandling af voksne patienter med recidiverende eller refraktær akut myeloid leukæmi (aml) med en mutation flt3.

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm generics a/s - lorazepam - tabletter - 1 mg